In breast cancer cells, KAI1-SP provoked a prominently enhanced cell proliferation, whereas, in contrast, KAI1-WT expression led to a reduced proliferative activity, even below that of wt and vector-transfected cells. Here, CD82 is linked to breast carcinoma.